RONGZUN INT'L (01780) appoints Winbo Capital as independent financial advisor.
Rongzun International Holdings (01780) announced that Wangbo Capital Limited (a corporation licensed to conduct Type 1 (securities trading) and Type 6 (advising on corporate finance) regulated activities under the Securities and Futures Ordinance) has been appointed as the independent financial advisor to provide advice to the independent board committee and independent shareholders on the takeover offer (especially on whether the offer is fair and reasonable and should be accepted), and such appointment has been approved by the independent board committee in accordance with Rule 2.1 of the Takeovers Code.
RONGZUN INT'L H (01780) has announced that Vermilion Capital Limited (a corporation licensed under the Securities and Futures Ordinance to conduct Type 1 (securities trading) and Type 6 (providing advice on corporate finance) regulated activities) has been appointed as the independent financial advisor to provide advice to the independent directors and independent shareholders on the offer (particularly on whether the offer is fair and reasonable and whether the offer should be accepted), and such appointment has been approved by the independent directors in accordance with Rule 2.1 of the Takeover Code.
Related Articles
.png)
XXF (02473) plans to offer a discount of about 2.38% in a rights issue, with a net proceeds of approximately HK$1.26 billion.
Hansoh Pharma (03692): HS-10541 tablets obtained the drug clinical trial approval notification letter issued by the National Medical Products Administration.
CF PHARMTECH (02652) spent HK$344,000 to repurchase 16,500 shares on May 13th.
XXF (02473) plans to offer a discount of about 2.38% in a rights issue, with a net proceeds of approximately HK$1.26 billion.
Hansoh Pharma (03692): HS-10541 tablets obtained the drug clinical trial approval notification letter issued by the National Medical Products Administration.
CF PHARMTECH (02652) spent HK$344,000 to repurchase 16,500 shares on May 13th.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
